Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)

China · Delayed Price · Currency is CNY

24.53

-1.02 (-3.99%)

Aug 21, 2026, 3:04 PM CST

SHE:300255 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Revenue	872.53	875.13	1,031	1,410	2,336	2,968
Revenue Growth	-12.32%	-15.10%	-26.92%	-39.63%	-21.29%	25.56%
Gross Profit	24.1	20.86	93.46	-322.77	1,021	1,722
Operating Income	-235.21	-236.07	-178.78	-1,145	107.99	324.06
Net Income	-355.81	-357.9	-249.48	-1,240	17.51	233.57
Earnings Per Share	-0.39	-0.39	-0.27	-1.35	0.02	0.25
EPS Growth	-	-	-	-	-92.00%	-7.41%

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Biopharmaceutical	753.08	896.44	1,275	2,273	2,889
Others	122.05	134.37	135.77	63.32	79.01
Total	875.13	1,031	1,410	2,336	2,968

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Investments	187.32	128	236.44	230.92	797.8	543.21
Total Debt	2,699	2,565	2,542	2,367	2,490	1,739
Net Cash (Debt)	-2,512	-2,437	-2,305	-2,136	-1,692	-1,195
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.74	-2.66	-2.49	-2.32	-1.93	-1.28

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Cash Flow	-27.1	55.68	56.22	33.73	3.13	2.87
Capital Expenditures	-123.85	-123.36	-239.59	-239.32	-431.22	-308.08
Free Cash Flow	-150.95	-67.68	-183.37	-205.6	-428.1	-305.21
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Gross Margin	2.76%	2.38%	9.07%	-22.88%	43.71%	58.01%
Operating Margin	-26.96%	-26.98%	-17.34%	-81.17%	4.62%	10.92%
Pretax Margin	-40.59%	-40.67%	-24.94%	-87.33%	0.78%	8.77%
Profit Margin	-40.78%	-40.90%	-24.20%	-87.93%	0.75%	7.87%
FCF Margin	-17.30%	-7.73%	-17.79%	-14.58%	-18.32%	-10.28%

Dividends

Fiscal Year	FY 2022	FY 2021
Period Ending	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Dividend Per Share	0.005	0.026
Dividend Per Share Growth	-80.77%	-
Dividend Yield	0.09%	0.32%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
PE Ratio	-	-	-	-	287.58	31.99
Forward PE	-	12.44	12.44	12.44	12.44	12.44
PS Ratio	25.84	65.22	17.82	8.48	2.16	2.52